[EN] SULFOXIMINE SUBSTITUTED QUINAZOLINES FOR PHARMACEUTICAL COMPOSITIONS<br/>[FR] QUINAZOLINES SUBSTITUÉES PAR UNE SULFOXIMINE DESTINÉES À DES COMPOSITIONS PHARMACEUTIQUES
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2015082324A1
公开(公告)日:2015-06-11
This invention relates to novel sulfoximine substituted quinazoline derivatives of formula (I), wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
Sulfoximine substituted quinazolines for pharmaceutical compositions
申请人:EVOTEC INTERNATIONAL GMBH
公开号:US10093660B2
公开(公告)日:2018-10-09
This invention relates to novel sulfoximine substituted quinazoline derivatives of formula (I), wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
SULFOXIMINE SUBSTITUTED QUINAZOLINES FOR PHARMACEUTICAL COMPOSITIONS
申请人:Evotec International GmbH
公开号:EP3077383B1
公开(公告)日:2018-08-22
Srivastava, R. M.; Brown, R. K., Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1993, vol. 32, # 11, p. 1153 - 1155
作者:Srivastava, R. M.、Brown, R. K.
DOI:——
日期:——
A CONVENIENT SYNTHESIS OF<i>2H</i>-PYRAN-2-ONES AND OF 3- AND 5- BROMO-<i>2H</i>-PYRAN-2-ONES
作者:Stamatia I. Kotretsou、Minas P. Georgiadis
DOI:10.1080/00304940009356281
日期:2000.4
effective synthesis of 2-pyrones as well as bromopyrones starting with 2-hydroxy-pyran-3(6H)-ones. Our starting materials which are endowed with different functionalities have been used for a multitude of reactions.15 The reported procedure depending on the experimental conditions, may lead to 2-pyrones or bromopyrones. These products may be used as synthons for additional syntheses. The synthesis of the